Intelligent mobile health management for the risk of gastrointestinal bleeding in anticoagulated patients with cardiovascular disease.
Ting Li, Jingtao Zhang, Hua Li and 4 others
PMID 42307451WHAT IT FOUND
Anticoagulated cardiovascular patients with gastrointestinal bleeding who received a nurse-supported mobile health bundle had better hemostasis, lower rebleeding-risk score, more knowledge, less anxiety and depression, and higher satisfaction than routine nursing care.
Key findings
01The hemostasis response rate was 98.33% in the intelligent group and 86.54% in the conventional group (P=0.016).
02The intelligent group had a mean time to hemostasis of 23.59 hours versus 32.15 hours in the conventional group, and a lower post-implementation Glasgow-Blatchford score of 6.11 versus 7.97 (P<0.001).
03After implementation, the intelligent group had higher disease-awareness scores, lower anxiety and depression scores, and higher satisfaction (95.00% versus 76.92%).
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was single-center, retrospective and used convenience sampling, so the groups may not represent other hospitals or all anticoagulated patients. Patients were assigned by the nursing strategy already received, not by random allocation, so differences may reflect how care was chosen rather than the mobile health bundle itself. The intelligent intervention was a bundle of several components, including the app, wearable monitoring, nurse follow-up, education, psychological support and telemedicine, so the contribution of any single component cannot be separated. Follow-up was only four weeks after discharge, so long-term effectiveness was not evaluated. The paper does not name a single primary outcome, so it is unclear which finding should be treated as the main result. The disease-awareness questionnaire and nursing satisfaction scale were developed for this study, and the supplied text does not report reliability for the satisfaction scale. The paper does not describe randomisation, allocation concealment or blinding.
Declared interests
The study was financially supported by Grant No. AK2024-SF-19. The supplied text does not report a separate conflict-of-interest declaration.
The easy way to misread this
Do not conclude that the mobile app alone caused better bleeding outcomes. The intelligent group received a bundle that included the app, wearable monitoring, face-to-face training, nurse follow-up, medication and drug-interaction reminders, dietary guidance, symptom and emergency alert functions, health education, psychological support and telemedicine, alongside standard medical treatment, and patients were not randomised, so the effect of any one component cannot be separated.